Tiziana Life Sciences announces that its Scientific Advisory Board Chairman Dr. Howard Weiner received NIH grant to investigate Nasal Anti-CD3 for the treatment of Alzheimer’s disease

NEXT STORY
Impact of COVID-19 on the Infectious Disease Testing Industry, 2020-2025
PREV STORY
Novartis PREVENT data show Cosentyx® helps patients realize early and lasting relief in axial spondyloarthritis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Tiziana Life Sciences announces that its Scientific Advisory Board Chairman Dr. Howard Weiner received NIH grant to investigate Nasal Anti-CD3 for the treatment of Alzheimer’s disease

NEXT STORY
Impact of COVID-19 on the Infectious Disease Testing Industry, 2020-2025
PREV STORY
Novartis PREVENT data show Cosentyx® helps patients realize early and lasting relief in axial spondyloarthritis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Tiziana Life Sciences announces that its Scientific Advisory Board Chairman Dr. Howard Weiner received NIH grant to investigate Nasal Anti-CD3 for the treatment of Alzheimer’s disease

NEXT STORY
Impact of COVID-19 on the Infectious Disease Testing Industry, 2020-2025
PREV STORY
Novartis PREVENT data show Cosentyx® helps patients realize early and lasting relief in axial spondyloarthritis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ultimovacs announces first patient enrolled in Phase II FOCUS trial of UV1 in head-and-neck cancer

author_avatar
NASDAQ Market News

Ultragenyx Expands Leadership Team and Appoints Dr. Wladimir Hogenhuis as Chief Operating Officer

NOVATO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a ...

author_avatar
NASDAQ Market News

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020

author_avatar
NASDAQ Market News